NKp46 Antibodies

Santa Cruz Biotechnology delivers a wide array of NKp46 monoclonal antibodies for advanced research in immunology and cell biology. NKp46 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NKp46, also known as natural killer cell p46, is a critical activating receptor expressed on natural killer (NK) cells, playing a vital role in the immune response against tumors and viral infections. By recognizing specific ligands on target cells, NKp46 contributes to the cytotoxic activity of NK cells, enhancing the body's ability to eliminate infected or malignant cells. Understanding the function of NKp46 is essential for developing immunotherapeutic strategies and advancing our knowledge of immune regulation. Researchers worldwide rely on NKp46 monoclonal antibodies to investigate NK cell biology and immune system responses. Current studies utilizing NKp46 monoclonal antibodies are uncovering new insights into cancer immunotherapy and viral defense mechanisms. Ongoing research with NKp46 monoclonal antibodies continues to reveal important aspects of NK cell function and regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to advance scientific understanding and develop innovative therapeutic approaches.